Substituerede amidderivater som proteinkinaseinhibitorer

Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and...

Full description

Saved in:
Bibliographic Details
Main Authors CHOQUETTE, DEBORAH, BELLON, STEVEN, D'AMICO, DERIN, LEE, MATTHEW, HARMANGE, JEAN-CRISTOPHE, ROVETO, PHILIP, GERMAIN, JULIE, BAUER, DAVID, FELLOWS, INGRID M, LA, DANIEL, NORMAL, MARK H, XI, NING, YANG, KEVIN, KIM, TAE-SEONG, POTHASHMAN, MICHELE, GRACEFFA, RUSSEL, D'ANGELO, NOEL, SIEGMUND, AARON C, BOOKER, SHON, DOMINGUEZ, CELIA, HIRAI, SATOKO, LIU, LONGBIN, BOEZIO, ALESSANDRO
Format Patent
LanguageDanish
Published 04.02.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Bibliography:Application Number: DK20060751834T